The Warrington-based healthcare investor’s half year trading results on the London Stock Exchange show a continued determination to grow, with the addition of 27 properties to its portfolio between April and September.

The property additions include seven development completions and 20 acquisitions, which cost a total of £117m. The investor said that it now had 625 properties in its portfolio, with an annualised rent roll of £127.5m.

Assura said that it had also completed 11 disposals above March 2021 book value, which had landed the company proceeds of £15m.

Assura is on site with 12 of its developments, with a total cost of £72m. There are 20 projects in the immediate development pipeline, each of which is expected to be on site within a year. The cost for those projects is £145m. The extended development pipeline is estimated at a cost of £263m. These are schemes for which Assura will be working as the exclusive development partner with the NHS but are awaiting NHS approval. At £480m, the development pipeline is the largest ever for Assura, with the previous record having been the £405m pipeline reported in its results for the year ending March 2021.

The developer said that it was also currently on site with five capital asset enhancement projects with a £3.7m total spend.